| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 705327 | Null | 0.0171439890681608 | 0.38887056 |
| NSC 716524 | Null | 0.0171439890681608 | 0.30977675 |
| NSC 717708 | Null | 0.0171439890681608 | -0.013396089 |
| NSC 740160 | 2-{4-[4-(5-morpholino-1H-benzo[d]imidazol-2-yl)phenoxy]butyl }-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione | 0.0171439890681608 | 0.28924447 |
| NSC 743853 | Null | 0.0171439890681608 | 0.53778001 |
| NSC 749117 | 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline | 0.0171439890681608 | 0.29270776 |
| NSC 754109 | ethyl 8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate | 0.0171439890681608 | 0.18463139 |
| NSC 757982 | Null | 0.0171439890681608 | 0.47997892 |
| NSC 83715 | Null | 0.0171439890681608 | 0.38408609 |
| NSC 92915 | ANTINEOPLASTIC-92915 | 0.0171439890681608 | 0.6416279 |